The National Law Journal (subscription) has named its 2021 Plaintiffs’ Lawyers Trailblazers, a list that includes Lieff Cabraser partners Jonathan Selbin and Brendan Glackin. The award recognizes 52 plaintiffs’ lawyers “all of whom prove to be born leaders and true agents of change.”
The Journal highlights Jonathan’s innovative work in the sexual abuse litigation against disgraced gynecologist George Tyndall and the University of Southern California which resulted in a $215 million settlement between the university and a class of thousands of women who were abused by the doctor. “It is the largest class-action sex abuse settlement in history and one of only a handful that settled as a class. But it was also groundbreaking because it brought sweeping changes campuswide at USC,” Jonathan noted. USC’s reforms resulting from this work have become a framework for other institutions, and Jonathan continues to push for similar changes in other cases.
The Journal focuses on Brendan’s seminal work as trial counsel in the class action against high-tech companies, including Apple, Google, and Intel, alleging that major Silicon Valley firms conspired to suppress the pay of technical, creative, and other salaried employees via illegal no-poach agreements. “It was the first certified no-poach case, and it was a big team effort, with our team at Lieff Cabraser breaking a lot of new ground in the area.” The case, which resulted in a $435 million settlement, was noted as the most significant antitrust employment case in recent history, and was widely recognized as a legal and public policy breakthrough.
Congratulations to both Jonathan and Brendan on this outstanding accomplishment!
About Jonathan D. Selbin
The Chair of Lieff Cabraser’s Economic Injury Product Defect practice group, New York partner Jonathan D. Selbin litigates consumer protection and defective product class action lawsuits against many of the nation’s most prominent corporations.
Cases in which Jonathan has played a lead role have resulted in court-approved class action settlements with combined total payouts to class members exceeding $3.4 billion in cash, plus other relief, such as extended and enhanced warranties.
In 2017, Jonathan and his family founded the Selbin Voting Rights Fellowship at Equal Justice Works, funding a rolling two-year fellow working to ensure fair access to voting in at-risk communities.
About Brendan P. Glackin
The Chair of Lieff Cabraser’s Antitrust practice group, San Francisco partner Brendan P. Glackin has represented direct purchasers of titanium dioxide in a nationwide antitrust class action lawsuit ($163.5 million in settlements); direct purchasers of flat-panel TV screens in litigation against the world’s leading LCDs manufacturers for conspiring to fix prices ($470 million in settlements; retailers in a monopolization pricing lawsuit against Abbott Laboratories charging that the company exploited the market for AIDS medicines used in conjunction with Abbott’s prescription drug Norvir, and employees in the high-tech workers class action alleging that major Silicon Valley firms colluded to reduce competition for workers.
Brendan has contributed groundbreaking work in litigation against drug makers for blocking access to affordable generics. This includes the blockbuster brand-name prescription drug Cipro ($399 million in settlements), which led to a 2016 “California Lawyer Attorney of the Year” (CLAY) award. Brendan continued his work in the field of generic drugs as lead counsel for Nashville General Hospital (the Hospital Authority of Metropolitan Government of Nashville) in a class-action antitrust case against defendants for monopolizing enoxaparin, the generic version of the blockbuster life-saving anti-coagulant Lovenox, which in 2019, settled for $120 million, the second largest indirect-purchaser antitrust pharmaceutical settlement fund in history, after Cipro.